SCHEMBL2643474

SCHEMBL2643474

CC(C)S(=O)(=O)c1ccc(C[NH])cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
CA2 P00918 3/20 0.36
PSIP1 O75475 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
ATR Q13535 2/20 0.34
ATM Q13315 1/20 0.34
MMP1 P03956 3/20 0.33
MMP13 P45452 3/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10060475 0.82 ALDH1A1 (0.40) ALDH1A1CA2MMP1MMP13CA12
SCHEMBL9908319 0.81 CA2 (0.57) ALDH1A1CA2PSIP1PTGDR2ATM
SCHEMBL1941299 0.79 ALDH1A1 (0.42) ALDH1A1BCHEACHECA2PSIP1
SCHEMBL4547863 0.79 CA2 (0.55) ALDH1A1CA2PTGDR2CA12CA1
SCHEMBL17342747 0.79 IDO1 (0.43) ALDH1A1CA2PSIP1PTGDR2ATR
SCHEMBL506866 0.79 PSIP1 (0.59) ALDH1A1CA2PSIP1ATRATM
SCHEMBL20372777 0.78 ALDH1A1 (0.44) ALDH1A1CA2PSIP1PTGDR2ATR
SCHEMBL16186188 0.78 CA2 (0.60) ALDH1A1CA2
SCHEMBL5325318 0.76 CA2 (0.58) ALDH1A1CA2CA12CA1CA4
SCHEMBL17315251 0.76 CA2 (0.60) ALDH1A1CA2PSIP1ATRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765789-B2 2-pyridinecarboxamide derivatives MSD K.K. (JP) 2014-07-01 US disclosed
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2013-04-04 US disclosed
US-8344003-B2 2-pyridinecarboxamide derivatives MSD K. K. (JP) 2013-01-01 US disclosed
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2010-02-18 US disclosed
US-7629362-B2 2-pyridine carboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-12-08 US disclosed
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-16 US disclosed
EP-1598349-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 ALDH1A1 1207/4885BCHE 3551/4885ACHE 3373/4885
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives GCKR, GCK, HK2 ALDH1A1 1249/4885BCHE 3556/4885ACHE 3397/4885
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 ALDH1A1 1207/4885BCHE 3551/4885ACHE 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.